SAN FRANCISCO--(BUSINESS WIRE)--Endosense, a medical technology company focused on enabling the broad adoption of catheter ablation for the treatment of cardiac arrhythmias, has announced that it will debut five groundbreaking abstracts in support of its TactiCath™ force-sensing ablation catheter at Heart Rhythm 2008, the Heart Rhythm Society’s 29th Annual Scientific Sessions, in San Francisco, May 14-17.
